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The effect of eye protection on SARS-CoV-2 
transmission: a systematic review
Oyungerel Byambasuren1* , Elaine Beller1, Justin Clark1, Peter Collignon2 and Paul Glasziou1 
Abstract 
Background: The effect of eye protection to prevent SARS-CoV-2 infection in the real-world remains uncertain. We 
aimed to synthesize all available research on the potential impact of eye protection on transmission of SARS-CoV-2.
Methods: We searched PROSPERO, PubMed, Embase, The Cochrane Library for clinical trials and comparative obser-
vational studies in CENTRAL, and Europe PMC for pre-prints. We included studies that reported sufficient data to esti-
mate the effect of any form of eye protection including face shields and variants, goggles, and glasses, on subsequent 
confirmed infection with SARS-CoV-2.
Results: We screened 898 articles and included 6 reports of 5 observational studies from 4 countries (USA, India, 
Columbia, and United Kingdom) that tested face shields, goggles, and wraparound eyewear on 7567 healthcare work-
ers. The three before-and-after and one retrospective cohort studies showed statistically significant and substantial 
reductions in SARS-CoV-2 infections favouring eye protection with odds ratios ranging from 0.04 to 0.6, correspond-
ing to relative risk reductions of 96% to 40%. These reductions were not explained by changes in the community 
rates. However, the one case–control study reported odds ratio favouring no eye protection (OR 1.7, 95% CI 0.99, 
3.0). The high heterogeneity between studies precluded any meaningful meta-analysis. None of the studies adjusted 
for potential confounders such as other protective behaviours, thus increasing the risk of bias, and decreasing the 
certainty of evidence to very low.
Conclusions: Current studies suggest that eye protection may play a role in prevention of SARS-CoV-2 infection in 
healthcare workers. However, robust comparative trials are needed to clearly determine effectiveness of eye protec-
tions and wearability issues in both healthcare and general populations.
Keywords: COVID-19, SARS-CoV-2, Eye protection, Face shield, Infection prevention
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http:// creat iveco mmons. org/ licen ses/ by/4. 0/. The Creative Commons Public Domain Dedication waiver (http:// creat iveco 
mmons. org/ publi cdoma in/ zero/1. 0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
Facial protection—for both wearer and close con-
tacts—has been a crucial and controversial feature of 
the COVID-19 pandemic. For example, WHO recom-
mends eye protection (goggles or face shield) for health 
care workers caring for COVID-19 patients but are not 
currently recommended for those caring for COVID-19 
patients at home even when in the same room. A major 
uncertainty has been how much protection is provided 
by different forms and combinations of facial coverings.
We know that respiratory viruses such as SARS-CoV-2 
can enter the respiratory tract via the nose, mouth, or 
eyes and inoculation may occur via air-to-face or hands-
to-face. Early in the COVID-19 pandemic the mix of 
these routes was unclear, but now the air-to-face route is 
agreed to be an important factor in most cases. Less clear 
is what are the proportions of inoculation that occurs via 
the nose versus eyes. The cornea has ACE-2 receptors 
which may allow SARS-CoV-2 infection, but more likely 
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One of the earliest evidence for potential importance 
of eyes in infection transmission and therefore eye pro-
tection came from the Spanish influenza epidemic [2]. 
Despite evidence from the previous SARS and MERS 
outbreaks suggesting an impact of eye protection [3], 
the COVID-19 pandemic has seen much less research 
focused on eye protection. A call for face shields to pro-
vide eye protection early in the pandemic seemed to be 
largely ignored in both practice and research [4], despite 
some promising studies. One early observational study 
in India of healthcare workers dealing with COVID-19 
patients in the community showed a dramatic decline 
in the numbers of workers getting infected after face 
shields were made mandatory [5]. However, this study 
has received relatively little attention. A recent plea in the 
Lancet Microbe pointed to eye protection as a potential 
missing key [1].
Therefore, to examine the potential contribution of eye 
protection, we aimed to identify, appraise, and synthesise 
all studies that estimated the impact of any form of eye 
protection including face shields and variants, goggles, 
glasses, and others on transmission of SARS-CoV-2.
Method
We conducted a systematic review using enhanced pro-
cesses and automation tools [6]. We searched the PROS-
PERO database to rule out existence of a similar review; 
searched PubMed, Embase, and The Cochrane Library’s 
CENTRAL for clinical studies, and Europe PMC for pre-
prints from 1 Jan 2020 to 1 Jun 2021. A search string 
composed of MeSH terms and words was developed in 
PubMed and was translated to be run in other databases 
using the Polyglot Search Translator [7]. The search strat-
egies for all databases are presented in Additional file 1: 
Supplement 1. We also searched World Health Organi-
zation—International Clinical Trials Registry Platform 
(ICTRP) and ClinicalTrials.gov databases from inception 
until 1 Jun 2021. Protocol for this review was developed 
but not registered. We used PRISMA 2020 statement as a 
reporting guideline for this review [8].
All publication types and languages were included in 
the search. We also conducted forward and backward 
citation searches for included studies in the Scopus cita-
tion database.
Our inclusion criteria—based on participants, inter-
ventions, and outcomes—were:
• Participants: all studies in humans, whether commu-
nity or health care workers.
• Interventions: any form of eye protection, including 
face shields, goggles, or modified snorkel masks, with 
or without face masks.
• Comparators: No eye protection, with or without 
face masks.
• Outcomes: number of laboratory-confirmed infec-
tion with SARS-CoV-2.
We included any comparative study design (including 
before-and-after). We excluded studies if they did not 
provide sufficient data to make a comparison between 
eye protection and no eye protection; laboratory experi-
ments; and any other eyewear that was not designed for 
prevention of respiratory virus transmission.
Screening
Two authors (OB, EB) independently screened titles, 
abstracts, and full texts. Full text articles were retrieved 
by OB. Discrepancies were resolved by referring to a 
third author (PG). The selection process was recorded in 
sufficient detail to complete a PRISMA flow diagram (see 
Fig. 1) and a list of excluded (full text) studies with rea-
sons for exclusions are provided in Additional file 1: Sup-
plement 2.
Data extraction
Two authors independently extracted the following data 
from included studies:
a. Study characteristics: country, study type, study set-
ting, details of study PICO, timeframe,
b. Quantitative outcomes: total number of populations 
tested, total number of COVID( +) cases both before 
and after the intervention was mandated.
c. Number of cumulative COVID-19 cases in the com-
munity before and after the intervention, from exter-
nal sources when necessary.
Assessment of the risk of bias
Two authors (OB, EB) independently assessed the risk 
of bias for each study using the ROBINS-I for observa-
tional studies [9]. We identified the following confound-
ing domains relevant to most studies in order of most to 
least likely (Table 1):
a. change in risk of COVID-19 from before, during and 
after the intervention,
b. test frequency or who is being tested (i.e., because of 
change in those being followed for infection),
c. comparator (use or compliance with other PPE),
d. setting (community, hospital, COVID-specific ward).
We also identified the following two co-interventions 
that could be different between intervention groups 
and that could impact outcomes: (i) Addition of other 
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infection control measures. Particularly important in 
before-after studies; (ii) Frequency of testing for COVID-
19 (e.g., change in policy for testing, mandating of 
testing).
Data analysis
We planned to do meta-analyses when two or more 
studies reported the same outcome provided that the 
heterogeneity was sufficiently low. The forest plot of 
intervention effects was created using Review Man-
ager (RevMan) Version 5.4.1 (Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2014). 
For dichotomous outcomes, we used the odds ratios. 
We did not assess publication bias / small studies effect 
because fewer than 10 studies were included. Where data 
were missing, study authors were contacted.
Results
We screened titles and abstracts of 898 articles including 
14 registered trials and assessed 29 full text articles for 
inclusion (Fig.  1). Main reasons for exclusion were lack 
of primary data and laboratory experiments. Full list of 
excluded studies with reasons can be found in the Addi-
tional file 1: Supplement 2. Five published observational 
studies (in 6 reports) from 4 countries were included 
in the quantitative analysis [5, 10–14] (Table  1). Al 
Mohajer et al. [10] is a published full version of Hemmige 
et  al. [12], with more complete data and therefore, was 
included in the analysis. All included studies were con-
ducted on healthcare professionals [10, 11, 14] (HCPs), 
community health workers [5], and healthcare workers 
(HCWs, defined as all people working in healthcare envi-
ronment regardless of direct or indirect involvement in 
clinical activities [13]).
Fig. 1 Screening and selection of articles















































































































































































































































































































































































































































































































































































































































































Page 5 of 7Byambasuren et al. Antimicrob Resist Infect Control          (2021) 10:156  
Description of the eye protections ranged from 
wraparound eyewear and goggles to full face shield or 
visor in addition to approved masks and other infection 
control measures in the corresponding clinical setting 
(Table  1). Eye protections were mandated to be worn 
upon entry to the hospital [10], or during all patient 
interactions [5, 11, 13, 14]. Three of the studies insti-
tuted the eye protection intervention during the rise of 
community cases during the first wave of infections in 
the respective communities [10, 11, 14]. However, none 
of them adjusted for change in risk of infection (e.g., 
community rates).
The high heterogeneity between studies precluded 
a meaningful meta-analysis. Forest plot of each study 
outcomes are presented in Fig.  2. Most of the studies 
reported reduced number of infections after instigat-
ing eye protection for patient interaction. The three 
before-and-after studies all showed statistically signifi-
cant and substantial reductions in SARS-CoV-2 infec-
tions favouring eye protection with odds ratios ranging 
from 0.04 to 0.6, corresponding to risk reductions of 
96% to 40% [5, 10, 11]. However, the one case–control 
study reported odds ratio favouring no eye protection 
(OR 1.7, 95% CI 0.99, 3.0) [13]. None of the studies 
adjusted for potential confounders such as other pro-
tective behaviours.
We also found three prevalence studies that looked 
at potential protective effect of regular eyewear in gen-
eral population [15–17]. They suggested that wearing 
regular eyewear for more than 8  h a day could reduce 
SARS-CoV-2 infection, but there was insufficient data to 
establish causation.
Risk of bias
The risk of bias of the included studies was assessed by 
ROBINS-I for observational studies. The risk of bias 
within individual studies was judged overall as moderate 
to serious with confounding being the primary source 
(see Methods). Risk of selection bias, classification of 
intervention, measurement of outcomes and selection 
of reported results were judged to be low risk of bias 
(Table 2).
Discussion
Of the five observational studies identified, four showed 
substantial and statistically significant reductions in 
COVID-19 infections of health care workers after man-
datory eye protection—mainly from face shields—was 
introduced; one case–control study showed an increase 
which was partly explained by an increase in community 
transmission. All five studies were non-randomized, and 
did not adjust for potential confounders, so the overall 
risk of bias was high. Therefore, the evidence summa-
rised here is very low certainty.
One important confounder for the before-after studies 
is any change in community transmission between the 
before-after periods; as demonstrated in Fig. 2, the com-
munity rates were generally higher in the after period; 
hence adjustment would only increase the size of the 
estimated reduction. However, the higher rates may also 
mean increases in other protective behaviours which are 
not reported in any of the studies. Finally, while the stud-
ies’ main intervention was face shields, they also allowed 
the use of some other forms of eye protection such as 
goggles.
A previous review of observational studies on the 
effects in of eye protection in the SARS and MERS epi-
demics found a reduction in transmission of 66% and 
76% respectively [3]. These reductions are comparable 
with the reductions seen in the three before-after studies 
of this review. Several laboratory studies using mannikins 
have examined the potential effects of face shields but 
vary greatly in their design and their application to real-
world settings. One study tested facing mannikins 25 cm 
Fig. 2 Forest plot of effect of eye protection in healthcare professionals
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apart with the emitter sending an aerosol spray with par-
ticles with a range of size from less than 0.3 µm to 10 µm; 
they found a reduction in particles received of 55% 
with face shields compared to 22% for a mask, and 97% 
for both [18]. A study with a mannikin 60 cm from the 
spray found greater reductions and face shields provid-
ing greater protection than masks [19]. However, these 
studies were of water aerosols not transmission of viral 
particles and are very incomplete simulations of human 
interaction. Neither separated eye protection specifically 
from face protection.
These studies provide suggestive evidence that face 
shields provide some protective effect, and that this may 
be substantial. These studies cannot determine how much 
of the protective effect is due to reduction of transmission 
from the eyes via nasolacrimal duct to nose. Furthermore, a 
face shield—the main protection used—may provide addi-
tional inhalation protection as seen in some of the labora-
tory studies. While goggles also provide eye protection, 
face shields will likely give substantial protection against 
inhalation of droplets as well as eye protection and are 
more comfortable to wear. Hence face shields—in addi-
tion to masks—should be considered for higher risk situ-
ations—such as contact tracing, quarantine workers, and 
some primary care consultations—or when there is sub-
stantial Covid spread in the community. Additional pro-
tection is likely to be particularly important to health care 
workers in settings where currently only face masks are 
being used.
While these observational studies show an interest-
ing potential protection from face shields as add-on to 
face masks, they do not clarify whether such protection 
is from reduced inhalation or eye protection. Trials of the 
incremental value of face shields in addition or instead of 
face masks and comparative studies of face shields and eye 
goggles with face masks all seem warranted. Such studies 
should also measure comfort and adherence of different 
options used, as correct and sustained usage is also critical 
to effectiveness.
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Table 2 Risk of bias in included studies assessed by ROBINS-I
NI no information
Risk of bias domains
























Overall risk of 
bias
Al Mohajer [10] Moderate Low Low Low NI Low Low Moderate
Bhaskar [5] NI Low Low Low Low Low Low Moderate
Hamilton [11] Moderate Low Low Low NI Low Low Moderate
Rodriguez-
Lopez [13]
Serious Low Low NI Low Low Low Serious
Shah [14] Serious Low Low NI Low Low Low Serious
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